Immune checkpoint inhibitors in liver transplant: a case series

BACKGROUND: Immune checkpoint inhibitors (ICIs) in the setting of liver transplant (LT) pose a risk of rejection and hold unclear benefit in both the neoadjuvant (pre-transplant) and post-transplant salvage setting. In the pre-transplant setting, neoadjuvant ICIs may serve as a bridge to LT by downs...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudolph, Mark, Shah, Shimul A., Quillin, Ralph, Lemon, Kristina, Olowokure, Olugbenga, Latif, Tahir, Sohal, Davendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186520/
https://www.ncbi.nlm.nih.gov/pubmed/37201081
http://dx.doi.org/10.21037/jgo-22-922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186520/
https://www.ncbi.nlm.nih.gov/pubmed/37201081
http://dx.doi.org/10.21037/jgo-22-922

Ejemplares similares